Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2026-01-29 @ 1:04 PM
Study NCT ID:
NCT04080661
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2019-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.
Sponsor:
University Hospital, Ghent
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BC-02602 - BIOLOPTIM-SEC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None